Measuring Atomoxetine and Aroxybutinin In Patients With OSA

Condition:   Obstructive Sleep Apnea (OSA) Interventions:   Drug: AD109 (atomoxetine/aroxybutynin);   Drug: Atomoxetine Hydrochloride;   Drug: Placebo Sponsor:   Apnimed Not yet recruiting

Source: ClinicalTrials.gov - June 25, 2021 Category: Research Source Type: clinical trials